Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Canada Inspection
/
Glaxo SmithKline Biologicals

CANADA INSPECTION

•Glaxo SmithKline Biologicals•December 7, 2017

Canada Inspection 70178 - Glaxo SmithKline Biologicals - December 07, 2017

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This CANADA INSPECTION record concerns Glaxo SmithKline Biologicals, with an inspection on December 7, 2017, covering drugs.

Company: Glaxo SmithKline Biologicals
Inspection Date: December 7, 2017
Product Type: Drugs

Open in Dashboard

ID · 4f81276e-7bcd-430b-a0e8-bc2d0cbe0156

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

Canada Inspection 70178 - Glaxo SmithKline Biologicals - December 07, 2017 | Global Key Solutions